ACIP Presentation Slides: October 25-26, 2023 Meeting

At a glance

  • Note: These files are not yet 508.
  • Slides will be added as they become available.

October 25, 2023

Welcome & Introductions

Introduction

Dr. G Lee

Dr. M Wharton

Meningococcal Vaccines

Introduction [7 pages]

Dr. K Poehling

Plan for revisiting adolescent schedule for meningococcal vaccines [7 pages]

Dr. L McNamara

Comparison of Pfizer and CDC cost effectiveness analyses [25 pages]

Dr. I Ortega-Sanchez

Summary of EtR and proposed recommendations for Pfizer’s MenABCWY vaccine [42 pages]

Dr. J Collins

Mpox Vaccines

Introduction [17 pages]

Dr. P Sanchez

Updates about U.S. mpox epidemiology, vaccine safety, and vaccine effectiveness [40 pages]

Dr. F Minhaj

Evidence to recommendations framework [45 pages]

Dr. A Rao

Review of voting language and clinical guidance [15 pages]

Dr. A Rao

RSV – Adults

Introduction [8 pages]

Dr. C Kotton

GSK safety and immunogenicity in persons 50-59 years of age [26 pages]

Dr. S Gerber

Epidemiology of RSV in adults [39 pages]

Dr. M Patton

Work group interpretation and ACIP discussion [26 pages]

Dr. A Britton

Influenza Vaccines

Introduction [7 pages]

Dr. J Loehr

Safety of quadrivalent recombinant influenza vaccine in pregnant women and their infants [19 pages]

Dr. N Klein

Pregnancy outcomes with ccIIV4 (Flucelvax): results of a post-marketing study [13 pages]

Dr. G Sylvester

Safety of simultaneous versus sequential administration of mRNA COVID-19 and Quadrivalent Inactivated Influenza (IIV4) Vaccines: A randomized placebo controlled trial [37 pages]

Dr. C Walter

Safety of simultaneous vaccination with Zoster Vaccine Recombinant (RZV) and quadrivalent Adjuvanted Inactivated Influenza Vaccine (allV4) [31 pages]

Dr. K Schmader

Vaccine Safety Update

Update on COVID-19 and Influenza Vaccine Safety [20 pages]

Dr. T Shimabukuro